|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment of other intangible assets | |||||
| Interest and currency fluctuation of loans | |||||
| Severance pay, net | |||||
| Share-based compensation expense | |||||
| Decrease (Increase) in trade receivables, net | |||||
| Decrease (Increase) in other accounts receivable and other long- term assets | |||||
| Decrease (Increase) in inventories | |||||
| Increase in Deferred Tax Assets | |||||
| Decrease in operating lease right-of-use assets, net | |||||
| Increase in operating lease liabilities | |||||
| Increase (decrease) in trade payables | |||||
| Increase (decrease) in employees and payroll accruals, accrued expenses and other liabilities | |||||
| Increase (decrease) in advances deferred revenues | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Acquisition of Proteus and Microwave’s assets (Appendix A) | |||||
| Net cash (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of shares, net | |||||
| Proceeds from exercise of options and warrants | |||||
| Proceeds from short and long-term loans | |||||
| Repayment of short and long-term loans | |||||
| Net cash provided by (used in) financing activities | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at the beginning of the year | |||||
| Cash, cash equivalents and restricted cash at the end of the year | |||||
| Taxes | |||||
| Interest | |||||
| Operating lease right-of-use assets | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...